Picture this. A farmer walks into a busy community healthcare centre in rural Maharashtra seeking medical care for a toothache. He shares his history of long-term use of oral tobacco with a healthcare worker. A cursory examination of the mouth follows. The farmer is sent home with some painkillers. His stained teeth and white and red patches in the mouth, may have been noticed by the healthcare worker, but remain unaddressed. The patient - a long-term tobacco user - leaves the clinic with little further awareness of the imminent severity of these findings or actionable information to address them.

Far beyond a mere case study, this scenario is very common in healthcare practice across India. Precancerous oral lesions and oral cancer are easy to spot for a trained eye, however healthcare professionals are either unaware of, or poorly-versed with, screening for these findings, or lack the tools to evaluate high-risk lesions and initiate an urgent referral for confirmatory diagnosis and treatment.

India has over 250 million tobacco users, making it the world’s second largest consumer of tobacco products, with smokeless tobacco in the form of gutkha, pan masala mixed with zarda, and mishri, being the most common form of use.

With a large number of users, tobacco consumption is responsible for a staggering number of deaths in the country, estimated at 1.35 million deaths annually - which is over 3500 deaths daily or roughly 154 people per hour. This burden accounts for nearly 30% of adults (1 in 3 persons) using tobacco in some form.

In India, oral cancer caused by tobacco use is a leading cause of these deaths. Both smoked (cigarettes, bidis) and smokeless tobacco (such as gutkha, betel quid) are primary drivers for oral cancer, with a high prevalence of use in both urban and rural areas. Consequently, the country reports over 1,50,000 new oral cancer cases each year, with over 50,000 deaths due to the disease.

Tobacco-driven oral cancer is a multi-stage disease that starts when components in tobacco smoke or smokeless tobacco initiate a series of changes in the oral cavity, such as white patches, red patches, ulcers, thickened bands of tissue, among other lesions. Collectively referred to as ‘potentially malignant disorders’ (or ‘pre-cancer’), these lesions - while not cancerous themselves - possess a tendency to develop into oral cancer, usually over a period of several years. Detecting these lesions early can lead to medical interventions at a curable stage, thereby improving cancer survival and reducing morbidity and mortality.

Yet, in spite of the scale of the healthcare challenge and recognition of the value of early detection, screening for oral cancer in India is severely under-recognised and underutilised. India reports critically-low screening rates for the disease, with data from the National Family Health Survey-5 indicating that only 1% of women and men between 30-49 years have ever undergone screening for oral cancer. As a consequence, approximately 80% of oral cancers in India are diagnosed only when at advanced stages, an outcome associated with limited treatment options and poor survival rates. This discrepancy is in large part due to a paucity of effective screening tools for tobacco-driven oral cancer, particularly those that can be deployed at scale in underserved and resource-limited settings such as rural and remote areas.

It is this gap - between the healthcare need and technology-led innovation - that Mukhia+ is aiming to fill

Built by a team of clinicians and software developers based in India and the UK, Mukhia+ is a screening app for oral pre-cancer and cancer lesions, such as those resulting from long-term tobacco use. The app has been developed with the healthcare system in India in mind, including key considerations such as accessibility, rapidity, and affordability. The user-friendly tool requires only a smartphone and internet connectivity. Once downloaded, the app guides the user - intended to be a clinician, nurse, healthcare worker or trained operator - to capture select images from the oral cavity and upload them via a secure cloud-based server.

At this stage, the power of artificial intelligence kicks in. In ten seconds or less, an AI-based algorithm analyses the images and provides a colour-coded risk indicator that guides subsequent management. Lesions flagged as ‘high-risk’, such as those associated to be ‘potentially malignant disorders’ or with imminent risk of cancer progression require the user to advise the patient to seek urgent specialist attention. The app also provides each patient with a screening report that indicates key findings and subsequent recommendations.

Mukhia+ is powered by state-of-the-art technology from Edgescan.ai, a health tech startup company based at Lifepoint Multispecialty Hospital in Pune, and developed in collaboration with medical universities and dental colleges across India. The custom-built AI-based model is trained with over 50,000 images - each annotated by experts as well - from 5000 patients, covering more than 60 types of different oral lesions. The trained model has been validated across twenty diverse healthcare settings including hospitals, clinics, and corporate health initiatives. The results are more than encouraging.

Across multiple field sites, Mukhia+ demonstrated over 90% accuracy in detecting lesions suspicious for pre-cancer or cancer, with not a single case of cancer missed during real-world screening.

In one large corporate screening, Mukhia+ was used to screen 1014 tobacco users, where the AI-based model identified 850 lesions as ‘high-risk’ of which 777 turned out to be clinically-confirmed potentially-malignant lesions; a precision estimate of 92%, which is deemed acceptable for a screening tool. With its recently acquired ISO 13485 certification and CDSCO Class B license (as software as a medical device), the smartphone-based app is now positioned for use in industrial, hospital, and community-based health programmes.

Looking further, the deployment of Mukhia+ as a screening tool across India, as well as other countries with a high burden of tobacco use and tobacco-driven oral cancer, through national screening programs or cancer screening guidelines, can be a game-changer.

Going back to our initial case study, now picture this possibility. Prompted by the patient’s history of long-term tobacco use, the trained healthcare worker unlocks a smartphone that has the Mukhia+ app installed. Following the prompts on the app, the healthcare worker ensures the necessary security and data protection features and patient consent processes are in place. Then, using the Mukhia+ app, the worker photographs select sites in the patient's mouth. In the next ten seconds, the app analyses the images. The patient’s lesions are determined to be ‘high-risk’ for oral cancer. The patient is provided recommendations for further referral and follow up.

Karthik Krishna M, Dean of Rungta College of Dental Sciences and Research, Bhilai - a partner site where the model was field tested, says -

What I am most looking forward to is the potential of this app to scale up expert oral health screening in India and take it to the masses. For too long we have complained about oral cancers presenting in late stages. Mukhia+ has the potential to eliminate late presentations through timely action”.

While Mukhia+ undergoes further validation and evaluation in different settings, its ability to offer ease-of-use, large-scale and low-cost screening of tobacco-driven oral cancer makes it well-poised to transform the screening landscape and burden of oral cancer in India - and it promises to do so one picture at a time.

To know more about how you can engage with Mukhia+, write to ask@edgescan.ai.

An expanding landscape for science funding

Rajesh Gokhale, Secretary, Department of Biotechnology, during his keynote on the first day of YIM 2026, opened with a provocation that reframed the conversation before it had properly begun.

I just wish I were 25 today, as the world is so much more amazing. We could only have dreamt of doing impactful science. This is the opportunity of life”.

Later in the day, when a researcher returning from the US asked Shivkumar Kalyanraman, CEO, Anusandhan National Research Foundation, how ANRF relates to DBT and DST, and where a junior faculty member should apply, Kalyanraman was explicit:

It's not an 'either-or' proposition. It is an 'and' proposition. DBT and DST will continue to have their own programmes. We will try not to overlap with those. We tend to do things at the intersection of these entities... ANRF is an entity which, I keep joking, is like a movie. We bring everybody into a happy family and get them to collaborate. We are more of a collaborative entity that helps stitch together programmes across multiple stakeholders”.

The funding sessions that followed on day 2 were shaped by that tension: a landscape that, by many measures, is richer in opportunity than ever, yet one that early-career researchers continue to find difficult to navigate. Representatives from various funding agencies outlined the range of mechanisms available, from fellowships for researchers in the final stages of their postdoctoral fellowships to project-based extramural grants for those with established laboratories. While the funding landscape has grown considerably over the past decade, that growth in the number of schemes has not always been matched by clarity about how to navigate them. Kriti Sikri, Indian Council of Medical Research, said,

Each of the funding agencies has a very specific mandate which is set by the Government of India. Whenever you're applying for any of the grants, do look at the mandates and the vision of each of the organisations that you're applying to, and align yourself with the agency and with the particular call”.

A recurring theme among the national agency representatives was that funding priorities are not purely scientific but also policy-driven. One example was shared by Kuldeep Lal, Director, ICAR-Central Institute of Brackishwater Aquaculture, where he shared that ICAR's focus on food security, sustainability, and resource management was an example of how agency mandates shape what gets funded and what does not.

“A lot of times [ICMR] gets complaints that ‘Why have you rejected our project? We're working with medicinal plants’. If you're not showing the medicinal value of those plants, ICMR cannot fund you. So, align yourself with the national health priorities. With every call, there is a list of emerging national-level priorities. Read every call very well. This keeps updating with every call”, Kriti advised while discussing the necessity of mandate alignment.

What international and philanthropic funders bring to the table

Gerlind Wallon, European Molecular Biology Organization (EMBO), described the organisation's India-facing programmes not only as funding opportunities but as platforms for leadership development and global networking. She said,

We as scientists learn how to write a paper, how to think about our experiments, how to write grants more or less. But we do not learn how to run a lab, how to deal with the people in our labs and make our group successful, which is, of course, the most important”.

Speaking about the Scientific Exchange Grants, she said, “The success rate of these fellowships is around 50%. With a really decent project, you have a good chance to actually get it”.

The Human Frontier Science Program (HFSP) represented a different register entirely. HFSP programmes require cross-continental collaboration and carry high selectivity.

Philanthropic funding and flexibility in how they fund came into focus through talks from the Ignite Life Science Foundation and the Murty Trust. Shravanti Rampalli, CEO, Ignite Life Science Foundation said,

In most of the successful countries in research and innovation, the funding comes from private philanthropies and private organisations as well, which India lacks big time. We don't ask you for exhaustive 15-page proposals. For grants below 50 lakhs, our turnaround is 45 days. Within 45 days, we will get back to you, and in the next eight days, we will release the money”.

Turnaround time is the operational definition of agility for an ECR waiting to set up a lab. Neha Pankow, Director, Murty Trust, said what it means to be a Trust and not a section 8 company or how their mechanisms are different from CSR funding, “We don't have a board. The turnaround time for project decisions can be literally overnight in our case. The funds are disbursed to the institute but controlled entirely by the fellow. If the fellow is not happy at their host institute, they can move, and the entire funds move with them”. She added,

You want to hire the best postdoc, the best technician — you're going to have to offer them something competitive. With private funds, we say: go out and hire whomever you want”.

What funders are actually looking for

Across the different funding types, the panellists converged on a small number of expectations, but the discussion was more specific than a simple checklist.

On research questions, Kriti was direct: proposals that attempt to address several problems at once tend to fare worse than those that focus on a single question and pursue it rigorously. “Don't overpromise your objectives. Be more realistic and time-bound”, she advised the audience. She added, “Define measurable deliverables; what will you give at the end of three or five years? These have to be very definitive and beyond publications”.

A specific misunderstanding while finding collaborators is that adding names of senior collaborators automatically adds credibility. Kriti noted, “Show your team and institutional strength. Even if you are younger PIs and early-career researchers looking for mentors, align yourself and your project with your mentor's skill. It is not important to have big names on your project; that is not how things work. Align the skills. You should know where to tap into the skills of your mentor”.

Contrasting meaningful collaboration with performative partnership, Apurva Sarin, CEO, DBT/WT India Alliance, explained it to be, “a direction arising from your work that is best executed or explored in partnership with an individual from another discipline or capability. We do want you to diversify your portfolio and sample hopefully some of the joys of collaborating with individuals across different disciplines”.

What researchers asked and what the answers revealed

The ask-me-anything session surfaced several tensions that the spotlight talks had not fully addressed.

The distinction between grants for basic research and support for translational work or startups generated significant confusion. Shravanti addressed this confusion by naming the structural gap:

Much of the funding in our country is directed toward applications, inventions, and startups. “But to have originals for ourselves, if we have originals, do we have the bandwidth of scientists who can take it to the next level? That is also missing. If you have done research till TRL4, going to TRL8, where a company will come and pick you up, there are four more numbers which lie in between. How you work with those four numbers is something which is very important”.

Technology Readiness Levels (TRLs) came up repeatedly, with several researchers unsure whether they were expected to demonstrate applied relevance even for basic science proposals. Shravanti was clear when she said that TRLs are a consideration for translational funding, not for basic research proposals, and conflating the two unnecessarily constrains how researchers frame their work.

The most pointed exchange of the session came around institutional disadvantage. Several participants observed that funding tends to concentrate in a small number of institutions, and asked whether researchers at smaller or less-resourced institutes are effectively competing on an equal footing. “When we looked at where our travel fellowship applications were coming from, we were getting applications mostly from the same places: Bangalore, Hyderabad, and Delhi. There are approximately 580 research organisations in India that award PhD degrees, and fewer than 20% of applications come from these institutions. The rest of India, what is it doing”? Shravanti issued a provocation to the concern. She described the example of the Sohan Modak national travel fellowship as a concrete institutional response: “We have started this travel fellowship for students who are not from IITs and IISc but who are interested in pursuing research and coming from tier-2 cities”.

Grant disbursement delays, a complaint that has persisted in the Indian research community for years, came up again here. Shivkumar, in his keynote from day 1 had spoken about it too - “To be fully transparent, in the last ARG programme we got 12,600 proposals plus another 3,000 proposals. We got over 50,000 reviews. There tends to be greater dispersion in review quality. The country is maturing in the quality of its feedback. This will be a continuing work in progress. We hope to use AI in a responsible way, but with the provision that AI will not decide on your proposals. AI will help humans decide”. A helpful instruction from multiple panellists was to “pay equal attention to both the scientific aspects of the proposal and administrative compliance”.

Beyond the grant: What building a research career actually requires

From the ask-me-anything session and informal talks on YIM, what came across was that while a lot of informally obtained advice, albeit well-meaning, could discourage ECRs from applying to well-funded, high-absorption fellowships.

Apurva, in her talk about opportunities at the DBT/WT India Alliance, asked participants not to rely on the past, as some things will be different.

We are recommending that you start framing your proposals now — the full proposal, put in the abstract. If you're called, be very ready to put in your full proposal, because that time is also hugely reduced now”.

On day 1, to a postdoctoral fellow’s query on informal advice for not applying for Ramanujan fellowships, Shiv had a candid response - “Whoever is giving you the advice not to apply is unfortunately giving misguided advice. Each programme stands on its own feet. Once you become full-time faculty, you can apply for the Prime Minister's Early Career Grant and so on. Whatever grants you get, you can transfer them to whichever institution you go to”. L S Shashidhara, Director, National Centre for Biological Sciences (NCBS)-TIFR, was in the audience and added that the Ramanujan fellowship has an 80% absorption rate, which means 80% of fellows go on to secure permanent positions, which is quite high by global standards. The Ramalingaswami fellowship sits at 90%.

On a warm February morning at the Bangalore Life Sciences Cluster (BLiSC) campus in Bengaluru, a platform was set for thought-provoking discussions on the future of food encompassing climate change, healthy diet, and food security. The platform was the first edition of SUSTAiN (Sustainable Transformation in Agriculture and Nutrition), held on February 5-6, 2026, a new annual initiative by the Tata Institute for Genetics and Society (TIGS) in collaboration with the National Centre for Biological Sciences (NCBS) - TIFR. This initiative had leading institutes like University of Agricultural Sciences - GKVK, Bengaluru, ICAR - National Bureau of Agricultural Insect Resources (NBAIR), Bengaluru, and ICAR-Indian Institute of Rice Research (IIRR), Hyderabad as knowledge partners. The two-day conference witnessed over 250 participants, including scientists, students, policymakers, industry representatives, extension professionals, and other agricultural and environmental enthusiasts, who came together to discuss an important question: How do we design an agriculture system that can withstand the whims of climate change while providing sustenance for both people and the planet?

The central theme that surfaced during these discussions was the recognition that ‘agriculture is at the crossroads’. While contributing about 5% of global greenhouse gas emissions, the cultivation of crops remains highly vulnerable to rising temperatures, fluctuating rainfall, and pest attacks. Globally, agrifood systems are being pushed to do more with less; that is, to increase productivity, adapt to climate change, provide adequate nutrition, and reduce greenhouse gas emissions simultaneously. In addition, India is focusing on broader aspects related to resilience, nutrition, and farmer livelihoods. However, formulating and translating policies into practice is a process that involves discussions, brainstorming, and active engagement among stakeholders, as currently, there are limited opportunities to connect science, policy, and practice.

SUSTAiN is an annual conference designed to serve as a platform to integrate these components and provide a roadmap for an agricultural system that meets societal needs. The conference featured three key themes: climate-resilient agriculture, sustainable pest management, and sustainable nutrition security. Over 90 posters were displayed, covering topics ranging from molecular genetics and microbial applications to agricultural policy.

Enhancing climate resilience: A strategic shift toward multi-stress-resilient crop varieties

Climate-resilient agriculture is a critical frontier in food security, and the session emphasised that the era of single-trait solutions has ended in the face of agriculture’s mounting challenges. To confront modern challenges, crops must be resilient to diverse stresses, such as heat and drought, diseases and pests, flooding and nutrient imbalance, etc. Discussions highlighted new breeding techniques that combine multiple traits to yield high-performing varieties while maintaining grain quality and farmer acceptance. A new player on the block is genome editing, which offers precision and accelerates the development of these traits in plants. The session showcased precise genome-editing approaches that, when implemented responsively, could be highly beneficial. Scientists spoke about targeting hormone systems such as cytokinin metabolism in rice, which helps in increasing yield and stress tolerance. However, the journey of genome editing from the laboratory to the field is a work in progress, as identifying the correct target genes requires extensive genotype-to-phenotype data.

Another potential approach to improve crop stress resilience, yield, and nutrition among the plants is by enhancing soil and rhizosphere health through beneficial microbes. Microbial applications have been proposed as a sustainable solution for decades, but microbial synthetic community (SynCom) appears to be a more sustainable solution that may work across diverse environments. The prospect of reducing fertilizer dependency, one of the biggest environmental stressors, is particularly promising and offers scope for improved biological nitrogen fixation and plant-microbe interactions. Another focus was on multi-location trials and stress indices that evaluate crop performance under real-world conditions. The impact of rising night-time temperatures during grain filling, often overlooked in favour of daytime temperatures, was cited as an important factor in maintaining stable yields under stress.

Transforming pest management: an eco-friendly, sustainable approach

Climate change affects crop yield, diseases, and pest prevalence. A key discussion in the pest management sessions focused on the misuse of pesticides, which has led to insect resistance and ecological side effects.

Though integrated pest management has been touted as the most eco-friendly and sustainable way forward, the speakers also emphasised its limited adoption in India. In addition to established methods of physical and biological control, new scientific innovations such as microbial applications, bio-pesticides, RNA interference, and CRISPR technologies are advancing pest management and addressing pesticide resistance. Targeted pest control using plant RNAi machinery or dsRNA-based biopesticides may allow specific pest suppression without harming beneficial insects or microbial communities.

The forum strongly emphasised that a multidimensional integrated approach is essential for sustainable pest management. It was also highlighted that technology alone is insufficient; effective implementation requires coordination among research institutions, regulatory bodies, industry stakeholders, and farmers. Successful translation depends on scientific transparency, clear communication, and openness, which help build trust between scientists, industry actors, and farmers.

Nutrition security: Reframing agriculture through a nutritional lens

Beyond developing plants that withstand stress and increase productivity under climate change, another critical question remains: nutritional security. Questions arise about what we produce, for whom, and whether it is nutritionally adequate. A large part of the Indian population continues to suffer from deficiencies in key micronutrients. Although most of our daily energy requirements are derived from cereals, diets remain deficient in iron, zinc, protein, and essential vitamins. This disconnect between energy sufficiency and nutrient insufficiency remains a major public health challenge.

The third session of SUSTAiN 2026 emphasised the nutritional value of crops. Speakers stressed that the food system of today should not focus merely on producing enough grain, but must ensure the grains are nutrient-rich and capable of meeting human metabolic needs.

Biofortification, where crops are engineered to increase their levels of essential nutrients, was deemed essential during the discussions. Recent advances in genomics-assisted breeding have produced cereals with an adequate amount of iron, zinc, and protein, while maintaining parity in quality and productivity with conventional varieties. Nutrition security, therefore, concerns itself with access, where nutritious crops become a mainstream component of the food system, and delivering better health outcomes does not require individual effort but becomes a part of a regular diet.

Bridging divides: Science, policy, and practice

The final session, an interactive panel discussion, explored a fundamental question, “Why, despite scientific progress, are sustainable practices not scaling up sufficiently?” Issues such as institutional fragmentation, regulatory uncertainty, and limited private-public partnerships were identified as major barriers.

One key insight was that malnutrition can often be viewed as a “failure of exposure”. Caloric sufficiency does not necessarily translate into nutritional adequacy. Expanding access to reliable, science-based information about balanced dietary practices is therefore essential. The topic of direct-seeded rice was debated enthusiastically. While it promises methane reduction and water savings, concerns remain regarding yield stability and farmers' confidence. Opportunities to use microbes as biofertilizers and biocontrol agents to reduce greenhouse gas emissions while maintaining yields were also emphasised. Public-sector scientists highlighted the need for faster engagement between public institutions and private stakeholders.

A beginning

As the conversations drew to a close and the posters rolled up, one message lingered: transformation is not about the next breakthrough. It is about the continuous integration among genes and soil, crops and markets, and science and society within ethical and policy frameworks.

Across presentations, a recurring theme was the need to translate laboratory success into real-world applications that benefit farmers and consumers.

SUSTAiN 2026 did not claim to deliver a single solution to the climate-food-nutrition challenge. What it offered instead was something equally important: a space to collectively examine the interconnected pieces of the puzzle. In a world where the climate is uncertain, the only constant may be the adaptive evolution of food and nutrition security.

Historically, ecological sciences in India were concentrated at a handful of institutions: Indian Institute of Science (IISc), Bengaluru; Wildlife Institute of India (WII), Dehradun; National Centre for Biological Sciences (NCBS-TIFR), Bengaluru; Salim Ali Centre for Ornithology and Natural History (SACON), Coimbatore and several non-government entities such as World Wide Fund for Nature-India (WWF-India), Wildlife Conservation Society, (WCS), Nature Conservation Foundation (NCF), and Ashoka Trust for Research in Ecology and the Environment (ATREE).

Over the past fifteen years, however, a significant shift has taken place, with over fifty faculty members, mostly young investigators, establishing research programmes across a broader range of institutions, including IISERs, new private universities such as Krea University, Ashoka University, Azim Premji University, GITAM Deemed to be University, and several others. This expansion is timely, given the urgency and scope of impact of climate change and anthropogenic habitat loss in India’s biodiverse landscapes.

Despite this growth, several challenges remain. Researchers at many institutions often work in isolation, frequently as the only domain specialists, bearing disproportionate administrative and training loads, with limited opportunities for collaboration or resource-sharing.

The RYIM at Tirupati was conceived as a response to this fragmentation, bringing together young ecologists alongside senior researchers, funding bodies, and administrators.

Building on an earlier gathering in 2024, the RYIM Tirupati 2026 was designed with five objectives:

1. To discuss career trajectories and enable learning from senior researchers.

2. To address funding challenges and explore long-term strategies.

3. To examine administrative challenges specific to the domain.

4. To develop collaborative approaches to teaching and training.

5. To identify research directions and enable partnerships.

The meeting was structured across three days, combining plenary talks, panel discussions, breakout sessions, and field exposure to the Eastern Ghats. The event allowed both formal learning and informal networking across a growing community of ecologists.

Career journeys and scientific pathways

RYIM Tirupati began with the IndiaBioscience-led interactive Crafting Your Career (CYC) workshop. Moumita Mazumdar from the IndiaBioscience team introduced participants to diverse career pathways, while also providing insights into essential skill sets and the importance of networking, through a mix of informational interviews, résumé-building sessions, and discussions grounded in case studies and lived experiences.

The afternoon featured an outreach visit to Krea University. At Krea, delegates were given a tour of the facilities led by Vaishali Sharma, followed by structured interactions with faculty from three departments: Biological Sciences, Environmental Studies, and the Centre for Writing & Pedagogy. These interactions included lab visits, showcasing of laboratory instruments and facilities, and informal conversations around participants’ research areas and ongoing work.

Day 1 opened with a keynote address by N Parthasarathy, Emeritus Professor at Pondicherry University, Puducherry, who reflected on building a long-term research career in ecology. Drawing on decades of field-based work, his talk emphasised persistence, collaboration, and adaptability. Establishing long-term ecological datasets across multiple landscapes was highlighted as critical, along with the importance of relationships with collaborators and forest departments. He advised patience and perseverance in navigating administrative challenges, keeping organised records, and building relationships with Forest Departments over time. Diversifying funding across DST, DBT, MoEFCC, ONGC, and European sources was equally important, he said. He closed with a thought that captured his entire philosophy — "From seed to tree — sow now".

Subsequent sessions by young investigators Anusha Shankar, Vincy K Wilson, and Eapsa Berry reflected diverse research problems within ecology, showcasing work spanning systems from birds to insects. These discussions created space for early-career researchers to situate their own journeys within a broader context.

Funding landscape and strategies

A key session focused on funding challenges in ecological research, featuring Uma Ramakrishnan (NCBS-TIFR, Bangalore), N Parthasarathy (Pondicherry University, Puducherry), Robin VV (IISER Tirupati), and Jahnavi Joshi (CSIR-CCMB, Hyderabad), and moderated by Shivani Jadeja (Krea University, Tirupati). Discussions centred on three themes: types of funding, the role of networks, and institutional support.

Fellowships were seen as more flexible compared to grants, which often come with rigid deliverables. Small grants, particularly from Forest Departments, were recognised as crucial for exploratory work, even as larger grants carry greater visibility. Short funding cycles were noted as a limiting factor for long-term ecological research.

The “patchwork quilt” approach, combining multiple small grants, emerged as a common strategy, though administratively demanding. The consensus was that while fundraising is constant, opportunities exist, and researchers must learn to navigate them.

Views differed on the role of networking. While some emphasised the significance of strong science and proposals, others acknowledged that reputation, institutional affiliation, and relationships do influence outcomes. Practical advice from panellists included targeting appropriate calls and understanding funding probabilities.

Institutional support was identified as a key factor. Start-up grants and sustained internal funding were seen as essential for establishing research programmes. Models where institutions provide long-term support were highlighted as enabling more stable and impactful research.

From uncertainty to impact: A journey in science

Day 1 concluded with a plenary lecture by Uma Ramakrishnan from NCBS–TIFR, who shared a candid account of her scientific journey, highlighting its non-linear nature. Her PhD years were marked by disruptions, including a shift in research direction and an unsupportive environment. A positive postdoctoral experience later helped her rebuild confidence, underscoring the importance of a supportive research ecosystem.

On returning to India, Uma established a population genetics lab at NCBS while balancing motherhood and research. Her early, student-driven work led to key contributions in tiger genetics and directly informed conservation policy, including wildlife corridor design. Her recent work spans the genetic basis of the black tiger phenotype in Similipal and disease ecology in Northeast India, including bat surveillance during COVID-19. She also reflected on navigating institutional and public pressures, emphasising the role of institutional support. Her talk highlighted how long-term ecological research can translate into meaningful conservation impact.

Day 2 began with an insightful keynote by Hema Somanathan from IISER Thiruvananthapuram, who shared a deeply personal account of how her career was shaped by serendipity, frugality, and intellectual curiosity, reiterating the non-linear nature of research pathways. From early work at the Bombay Natural History Society (BNHS) in Mumbai to navigating a career break for caregiving, her trajectory reflected both challenges and renewal, particularly during her postdoctoral work in Europe. At IISER Thiruvananthapuram, she has since built a research programme focused on insect–plant interactions and social systems. She emphasised the value of interdisciplinary work, frugal science, and the exploration of understudied questions, noting that meaningful insights often emerge from such approaches.

Together with the previous day’s plenary, her talk underscored themes of resilience, adaptability, and curiosity, offering important perspectives, particularly on challenges faced by women in science.

The session was followed by Young Investigator talks by Mansi Mungee, Gopal Murali, and Ashwini V Mohan.

Administrative challenges and institutional realities

A panel on the second day, featuring Vinay Nandicoori (CSIR-CCMB, Hyderabad), S Sivakumar (Krea University, Tirupati), Hema Somanathan, and Uma Ramakrishnan, moderated by Guha Dharmarajan (Krea University, Tirupati), discussed administrative challenges and the perception of ecological research within institutions. A central theme was the importance of relationships with administrative staff. Participants were encouraged to view administrative personnel as collaborators rather than obstacles.

Navigating procurement systems and institutional processes requires patience and familiarity. Faculty roles were described as inherently managerial, involving responsibilities beyond research, including permits, logistics, and people management.

Institutions where administrative systems actively support scientific work were presented as effective models. Overall, the discussions underscored that conducting research in India often depends as much on human relationships as on formal systems.

Training, teaching, and community building

The meeting also addressed challenges in ecology training and education. Many institutions have limited faculty strength in ecology, leading to high teaching loads and reduced research time. The idea of a Teaching Consortium was revisited, aiming to pool expertise across institutions and enable collaborative teaching.

Breakout sessions allowed participants to identify key structural challenges, including establishing long-term field stations, obtaining ethics clearances for ecological research, and balancing teaching with research responsibilities.

Students participated in parallel discussions, raising concerns specific to early-career stages. These interactions highlighted the need for structured mentorship and institutional support mechanisms.

Key takeaways and broader impact

RYIM Tirupati highlighted both progress and persistent structural challenges.

For young investigators, the meeting provided access to mentorship, institutional perspectives, and peer networks — resources often limited in smaller or remote institutions. For aspiring researchers, it offered insight into the realities of academic careers in ecology.

At a broader level, strengthening ecological research networks has direct implications for conservation and policy in India. As the complex challenges of climate change and habitat loss intensify, the need for long-term, collaborative, and multi-site research becomes increasingly urgent.

Recommendations that emerged from RYIM Tirupati

The meeting concluded with several recommendations to address structural challenges and sustain momentum:

• Targeted publications in journals to raise awareness among scientists and administrators about field-based ecological research challenges.

• Focused white papers on teaching frameworks,ethics clearances for ecological fieldwork, administrative and funding/budgeting challenges.

• Community platforms, such as a dedicated WhatsApp group, to share administrative knowledge and troubleshoot challenges.

• Periodic follow-up meetings across different locations to maintain engagement and strengthen networks.

All pictures are taken by the RYIM Tirupati team at IISER Tirupati except the one from the visit which was taken by the team at Krea University.

In a series of pioneering studies (1, 2, 3) led by Gayathri Govindaraju, carried out at the Rajiv Gandhi Centre for Biotechnology (RGCB), Thiruvananthapuram, and the Department of Biotechnology, IIT Madras, under the guidance of Arumugam Rajavelu, researchers uncovered how Apicomplexan parasites including Plasmodium falciparum modify their RNA to regulate gene expression. While the core work focused on P. falciparum, this represents the first systematic report of RNA methylation machinery in any Apicomplexan parasite, marking a significant milestone from Indian laboratories.

Why RNA modifications matter

RNA is commonly described as a messenger that carries instructions from DNA to produce proteins. However, RNA molecules are far from passive. They are decorated with chemical modifications that influence RNA stability, translation efficiency, and lifespan. Such modifications allow organisms to rapidly fine-tune gene expression without changing their DNA sequence, a feature especially valuable for parasites that must adapt quickly to hostile host environments.

A parasite-specific RNA methylation system

One of the earliest discoveries from this work was the identification of a DNA methyltransferase homologue, TRDMT1 (tRNA aspartic acid methyltransferase 1), in P. falciparum. Unexpectedly, this enzyme did not modify DNA. Instead, it was proven as a tRNA methyltransferase, specifically catalysing cytosine-38 (C38) methylation of endogenous aspartic acid tRNA.

This modification is critical for the efficient translation of proteins enriched in aspartic acid residues, many of which are essential for parasite survival and virulence. In addition, tRNA C38 methylation appears to protect parasite tRNAs from cellular stress, potentially contributing to resilience against drug pressure. This finding challenged long-held assumptions about methyltransferase function and highlighted how malaria parasites repurpose conserved enzymes for parasite-specific needs.

m6A: A new layer of mRNA regulation

Building on these findings, the research team explored whether messenger RNAs in P. falciparum also carry chemical modifications. Using biochemical and molecular approaches, they provided evidence for N6-methyladenosine (m6A) modifications on parasite mRNA.

How the parasite “reads” m6A marks

Chemical marks on RNA are biologically meaningful only if cells can interpret them. In higher eukaryotes, m6A marks are recognised by specialised YTH-domain proteins, which bind methylated RNA and regulate its fate. Whether malaria parasites possessed such “reader” proteins was previously unknown.

This study identified a YTH2 domain–containing protein in P. falciparum that specifically recognises and binds m⁶A-modified mRNAs. Functional analyses demonstrated that this interaction modulates protein translation by regulating the efficiency with which methylated transcripts are translated into proteins. Collectively, these findings establish that malaria parasites harbour a complete m⁶A regulatory axis-comprising writers, readers, and m⁶A-modified-RNAs previously believed to be exclusive to higher eukaryotes. Notably, P. falciparum lacks canonical m⁶A erasers (RNA demethylases), underscoring the multifaceted and central role of the YTH2 reader in parasite gene regulation.

Why this matters for malaria control

P. falciparum undergoes rapid developmental transitions inside human red blood cells yet has limited transcriptional regulation. RNA modifications therefore act as a critical regulatory switchboard, enabling precise control of protein production throughout the parasite life cycle.

Importantly, several components of the parasite’s RNA methylation machinery are structurally and functionally distinct from human counterparts, making them attractive candidates for selective therapeutic targeting. Disrupting RNA methylation could impair parasite growth while minimising host toxicity.

In the battle between parasite and host, it’s no longer just the DNA that matters-but how RNA is written, read, and regulated”,

the author’s quote.

An Indian contribution to global parasitology

Epi-transcriptomics: the study of RNA modifications is a rapidly expanding field, largely explored in cancer and viral biology. Extending this framework to malaria parasites represents a major conceptual advance. By being the first to report RNA methylation systems in any Apicomplexan parasite, this work positions Indian research at the forefront of global parasitology.

The findings have been published in leading peer-reviewed international journals, including BBA – Gene Regulatory Mechanisms, Epigenetics & Chromatin, mBio, and the Biomedical Journal, with a recent piece in the Biomedical Journal further highlighting the translational relevance of this work.

Looking ahead

Future research could map RNA methylation across the parasite transcriptome, explore how these modifications change across life-cycle stages, and determine how disrupting RNA methylation affects parasite survival and drug resistance. Advances in sequencing technologies and computational analysis may further accelerate such studies.

By uncovering how Plasmodium falciparum writes and reads chemical marks on RNA, this research reveals a new regulatory layer in parasite biology, underscores India’s growing contribution to global biomedical science, and opens new possibilities for precision-targeted antimalarial strategies.

Attending the Young Investigators’ Meeting (YIM) for the first time as an organiser (and never as an investigator) offered a perspective that was different from reading past reports or hearing about the meeting from colleagues.

YIM 2026 was hosted at the Symbiosis International (Deemed University), Pune, in collaboration with Symbiosis Centre for Research and Innovation (SCRI). The meeting was co-organised by a team of faculty members from institutions across India, who worked with IndiaBioscience to shape the programme and discussions. Their involvement reflects the collaborative spirit within the life science community that has characterised YIM and IndiaBioscience since its inception.

Over five days in Pune, what stood out for me was not only the formal programme of talks and discussions, but also the quieter conversations unfolding in corridors, during coffee breaks, and at shared tables. YIM has been less about the sequence of sessions and more about creating a space where early-career investigators candidly shared the uncertainties of building independent careers, while mentors reflected on their own journeys through the ecosystem.

A space for community building and mentorship for early-career researchers

The 18th edition of IndiaBioscience’s annual flagship Young Investigators’ Meeting (YIM) concluded earlier this month in Pune (2–6 March 2026). Now close to two decades old, YIM has become a space where early-career life science researchers come together to reflect on the challenges of building independent research careers and to find mentorship from across the scientific ecosystem.

Over the years, recurring themes at YIM have ranged from framing strong research questions and identifying funding opportunities to navigating institutional hiring systems, mentoring PhD students, and balancing professional and personal milestones. Mentorship at the meeting emerges from many directions - senior scientists, institutional leaders, peers working in different disciplines, and professionals from sectors beyond academia. Each edition of the meeting adds around 80 investigators to the growing YIM community, which now includes more than 1,400 researchers across India and abroad.

The continued relevance of the meeting reflects a simple reality: while the ecosystem of life sciences in India has evolved, the need for spaces where early-career researchers can openly discuss career uncertainties and opportunities remains constant.

For many participants, YIM has led to collaborations, mentoring relationships, and professional connections that extend long after the meeting ends.

A diverse community of researchers

YIM 2026 brought together a wide cross-section of the life sciences community. Forty Young Investigators from 39 institutions across India and 35 postdoctoral fellows from 34 institutions in eight countries outside India were selected to participate. They were joined by nine mentors, mid- to senior-career researchers from academia representing diverse research backgrounds, along with speakers from government agencies, industry, science funding organisations, research management, science engagement, and policy.

Institutional representatives from 18 institutions also participated, sharing insights into their research programmes and outlining faculty hiring practices and career development opportunities within their institutions.

This diversity of institutions, geographies, and disciplinary expertise is a deliberate feature of the meeting’s design. Participants included researchers working across molecular biology, ecology, evolutionary biology, biomedical sciences, biotechnology, and interdisciplinary areas that intersect with policy and public engagement. The aim is not simply to gather early-career scientists in one place but to expose them to the range of environments in which scientific careers unfold.

Mentorship is central to YIM's design

Rather than relying solely on formal talks, the meeting is structured to create multiple opportunities for conversation between participants and mentors.

Structured sessions introduce researchers to key themes, including funding opportunities, leadership, and career development. These are complemented by breakout group discussions and informal networking breaks, where participants can ask candid questions about navigating the early stages of academic life. Such exchanges often draw on the lived experiences of mentors and speakers, who reflect on the challenges they faced while building research programmes, securing funding, and managing teams.

Our rapporteurs captured several of these conversations during the breakout discussions. In one room, participants deliberated on how to sustain research momentum when infrastructure, administrative support, or institutional facilities are limited. Mentors underscored collaboration, networking, and resource-sharing as practical strategies in such situations. When experiments stall, they suggested that literature reviews, journal clubs, and computational work can help sustain productivity. Celebrating small milestones was recommended as a way to maintain morale within research groups, while internships and short-term projects can re-energise students facing dips in motivation. Administrative delays, participants were reminded, often require persistence and constructive engagement with institutional leadership, particularly when researchers can demonstrate how their work benefits the broader institutional ecosystem.

A more detailed report on the breakout room discussions will follow.

Several speakers also reflected on how personal aspirations and institutional realities together shape scientific careers. Anna Barron spoke about establishing the Singapore Brain Bank in 2018 and the challenges of building research infrastructure while navigating cultural assumptions about brain donation. Manjari Jain described the balancing act of academic life, where teaching responsibilities, committee work, and administrative duties can limit time in the field. Mohan Balasubramanian reflected on a different kind of decision: choosing not to switch research areas during his postdoctoral years and instead pursuing a single scientific question - what mechanism generates the force required to divide a cell into two - for more than three decades.

Taken together, these reflections offered participants pragmatic advice on navigating uncertainty and working within institutional constraints. Many speakers emphasised that collaboration and supportive networks are often critical to sustaining scientific work over the long term.

The design of YIM allows these conversations to continue beyond the formal programme. Informal discussions during meals and networking breaks frequently become spaces where early-career researchers exchange experiences about grant writing, laboratory management, and the realities of establishing independent research programmes.

Conversations shaping early-career research

Across the five days of discussions, several themes emerged that reflect the evolving landscape of life sciences research in India.

One major focus was the funding ecosystem for early-career researchers. Representatives from national and international funding organisations discussed fellowship schemes, collaborative grants, and emerging translational funding models. These sessions emphasised the importance of clear research questions, well-designed collaborations, and careful proposal preparation in navigating competitive funding environments.

Our detailed report on the sessions on life science funding to follow.

Another recurring theme was the increasing importance of interdisciplinary and translational research. Speakers from academia, industry, and policy backgrounds discussed how scientific discoveries move from the laboratory to real-world applications. Conversations highlighted both the opportunities and the structural barriers to translating fundamental discoveries into technologies or therapies. Praveen Vemula, in his mentor talk, emphasised that impactful translation depends on choosing unmet clinical problems, fostering multidisciplinary teams, enabling collaborations, and sustaining funding within a supportive ecosystem.

Panel discussions also explored the evolving relationship between academia and industry. Participants examined how startups and collaborative partnerships can help bridge gaps between discovery and application, while also addressing practical issues such as intellectual property, funding strategies, and the role of academic researchers in entrepreneurial ventures.

Research integrity and open science emerged as another important topic. As India’s research output continues to expand, speakers discussed the importance of maintaining trust and transparency in the research process. Open data, shared research resources, and the responsible use of emerging technologies, such as artificial intelligence, were identified as critical components of a healthy research ecosystem.

The meeting also highlighted the growing role of science engagement and science policy. Speakers working in public engagement described their motivations, indicating how researchers can contribute to public understanding of science, participate in policy discussions, and connect scientific knowledge with societal challenges. These conversations underscored that scientific careers today often extend beyond the laboratory into broader public and policy contexts.

Career pathways and institutional ecosystems

An important component of YIM is the opportunity for participants to interact with institutional leaders and learn about faculty hiring practices and research environments across India.

Representatives from 18 academic and research institutions presented their research programmes, infrastructure, and recruitment processes, providing participants with insights into how institutions evaluate potential faculty members and support early-career researchers. These sessions also highlighted the diversity of institutional models across the country, from traditional research institutes to emerging interdisciplinary programmes and translational research centres.

As participants were paired with smaller groups of representatives over mentorship circles, the interactions offered a practical view of how research ecosystems operate, including expectations around teaching, funding acquisition, collaboration, and research leadership from early investigators.

Our report on the PDF Satellite Meeting is to follow.

Strengthening the early-career research ecosystem

As the life sciences ecosystem in India continues to expand, platforms like YIM play an important role in connecting researchers at a formative stage in their careers.

The meeting provides a space for early-career scientists to openly discuss the uncertainties of building research programmes while gaining exposure to opportunities across academia, industry, policy, and science engagement. By bringing together researchers from diverse institutions and disciplines, YIM also helps build a network that can support collaboration and collective learning within the community.

Eighteen years after its inception, the continued growth of the YIM community reflects the enduring need for such spaces. While the research landscape evolves, the fundamental questions early-career scientists face about mentorship, funding, collaboration, and institutional culture remain strikingly similar across generations.

For many participants, the most valuable outcome of the meeting is not only the knowledge shared during the sessions but the relationships formed through these conversations. As the YIM community continues to grow, these connections remain central to strengthening the broader life sciences ecosystem in India.

Vaginal Candida infections affect 3 in 4 women at least once in their lifetimes. In India, vulvovaginal candidiasis accounts for an estimated 25–60% of symptomatic vaginal discharge cases, though prevalence varies by region and study population. Their significant treatment barriers are the development of dense microbial layers ‘biofilms’, which contribute to antimicrobial resistance and infection recurrence.

Understanding the challenge

(This section explains why biofilms are such a formidable barrier and why new therapeutic strategies are urgently needed).

Candida albicans (C. albicans) is a dual-natured pathogen, commensal under normal conditions yet opportunistic when the vaginal environment shifts. Even small disturbances in the natural acidic pH can allow Candida to overgrow. Its partner in crime is biofilm formation, a protective layer that acts like a bodyguard for fungal cells, shielding them from antifungal drugs, immune defences, and everyday stressors. This process is why many women continue to experience repeated infections even after completing treatment.

As highlighted in our earlier work, vaginal Candida infections remain one of the most common reproductive tract infections worldwide, yet biofilm-associated cases are often underdiagnosed and undertreated.

Biofilms are not just passive barriers; they are dynamic microbial ecosystems that mature, disperse, and seed new infections, as research has shown.

This challenge shaped my PhD research question: could we design a novel, drug-loaded vaginal nanogel that targets both fungal cells and their biofilms?

Why a new drug? Because many existing antifungals struggle once Candida settles into a biofilm.

Why a gel? Because it adheres well to the vaginal cavity and remains in place long enough to exert its therapeutic effect.

Why nanoscale? Because tiny particles can penetrate deeper into vaginal tissues and deliver higher drug concentrations directly to the infection site.

Formulation mission: Research techniques

(The following section outlines the scientific approaches used to identify, test, and refine this nanogel formulation).

To identify the right drug candidate, we used computer-aided screening approaches to compare several candidates with existing antifungals. Luliconazole stood out for its anti-microbial activity against C. albicans, making it the most promising choice for our nanogel. In laboratory (in vitro) and animal (in vivo) studies, both luliconazole and the nanogel showed a favourable skin profile, Candida inhibition, and the ability to disrupt dense biofilms.

However, choosing the right drug was only half the challenge; the formulation itself had to be compatible with the biology of the vaginal environment. To address this, we developed a luliconazole‑loaded nanogel specifically designed for vaginal application. The gel was engineered to stick to the mucosal surface, release the drug slowly over time, and penetrate deeper tissue layers where biofilms persist.

When tested on clinical isolates from symptomatic patients, the nanogel significantly inhibited fungal growth and disrupted the architecture of mature biofilms. The biofilms were visualised by fluorescence microscopy, revealing fragmented layers and not clusters. Skin-safety tests using goat vaginal tissue further confirmed that the nanogel was non-irritant when applied locally.

Research relevance: Luliconazole, reimagined for biofilms

(This section highlights the research novelty uncovered in our work).

For the first time, luliconazole showed dual activity against C. albicans clinical isolates, both inhibiting fungal growth and disrupting established biofilm structures. Using clinical isolates from patients, we captured real-world disease behaviour, revealing previously unreported antibiofilm activity of luliconazole when delivered via a vaginal nanogel system.

To assess drug performance, we measured the minimum concentrations required to inhibit C. albicans growth, prevent biofilm development, and reduce established biofilms. In all cases, luliconazole achieved these effects at lower concentrations than standard antifungal therapy, reinforcing its selection as the lead drug for our proposed nanogel.

Translational impact

(This section highlights how the nanogel could translate into a practical therapeutic option for vaginal Candida infections)

This work bridges a critical gap in vaginal antifungal therapy. The combination of luliconazole with a nano-lipid gel offers a locally acting, easy-to-apply, and potentially cost-effective formulation strategy. The designed nanogel provides a tailored approach to disrupt C. albicans biofilms and improve therapeutic outcomes.

The formulation holds promise for clinical translation, particularly in settings where vaginal Candida infections are underdiagnosed and undertreated. Future studies may explore advanced delivery platforms for both acute and chronic vaginal Candida infections, thereby strengthening the translational pipeline for innovations in women’s healthcare.

Ishu Saraogi, Associate Professor, Organic Chemistry and Chemical Biology, Indian Institute of Science Education and Research Bhopal (IISER Bhopal) and her PhD student at the time of publication of the study, Purnima Mala (now a postdoctoral researcher in RNA biochemistry at the University of Massachusetts Amherst (UMass), USA), showed that introduction of 2,6-Diaminopurine (D) at the 3’ position of the anticodon (5’-CUD-3’) in the suppressor tRNA (tRNACUD), which recognises the 5’-UAG-3’ stop codon, significantly strengthens this codon–anticodon interaction relative to that involving the normal suppressor tRNA (tRNACUA) anticodon 5’-CUA-3’.

This stronger interaction enables the suppressor tRNA to efficiently compete with release factor 1 (RF1) for 5’-UAG-3’-binding, thereby preventing the premature termination of translation (protein synthesis). In contrast, RF1 displaces tRNACUA, triggering the subsequent disassembly of the ribosome (translation machinery).

Protein synthesis naturally utilises only 20 standard (canonical) amino acids in most organisms. Normally, a specific transfer RNA (tRNA) is covalently attached to a particular amino acid (aminoacylated) by a dedicated aminoacyl tRNA synthetase enzyme. Each codon (triplet of consecutive nucleotides) in messenger RNA (mRNA) binds to its cognate aminoacyl tRNA via the latter’s anticodon nucleotide-triplet. Codons and their anticodons have complementary sequences (RNA sequences are read from the 5’ end to the 3’ end. Complementary sequences bind each other through specific hydrogen bonds between the nucleotides ‘A’ and ‘U’, and between ‘G’ and ‘C’, when the interacting nucleotides from complementary sequences are positioned opposite one another and the 5’-to-3’ orientations of the complementary sequences run antiparallel).

Over the decades, researchers have developed and refined stop codon readthrough technologies for encoding non-natural (non-canonical) amino acids (NAAs) (Learn more through this review article). This strategy involves expanding mRNA’s genetic code by attaching an NAA to a ‘suppressor’ tRNA, which is engineered to recognise one of the stop codons - 5’-UAG-3’ (Amber), 5’-UAA-3’ (Ochre), or 5’-UGA-3’ (Opal/Umber). Since multiple different stop codons provide beneficial redundancy for translation termination, one stop codon can be repurposed to encode an NAA while another signals termination at the 3’ end of the mRNA.

In this study, the incorporated NAA was (7-hydroxycoumarin-4-yl) ethylglycine (7-HMC), which was conjugated by coumaryl tRNA synthetase to an optimised tyrosyl tRNA derived from Methanocaldococcus jannaschii. The 7-HMC was encoded by either one or two Amber stop codons (with three different two-Amber-site positional variants) introduced into green fluorescent protein (GFP) by mutation. Translation was carried out in the Escherichia coli T7 S30 cell-free translation system. 14C-leucine autoradiography revealed yields of intact GFP, relative to unmutated GFP yield (defined as 100%), as tabulated below:

*due to inefficient stop codon read-through

Jiantao Guo, Professor, Chemical Biology, University of Nebraska-Lincoln, Nebraska, USA, who was not associated with this study, commented on the applications of this technique: “Enhancing codon–anticodon interaction enables more efficient incorporation of noncanonical amino acids. This methodological advance can augment current efforts to expand protein chemical diversity, thereby accelerating studies of protein structure, dynamics, and post-translational modifications, while empowering the design of new biotherapeutics, such as site-specifically modified antibodies and controllable protein drugs, with improved stability, specificity, and tailored biological functions”.

Chickpea (Cicer arietinum L.), the world’s second-most widely cultivated pulse, covers nearly 14.84 million hectares globally and forms a nutritional backbone for millions. As a protein-rich food and nitrogen-fixing crop, chickpea sustains both diets and soils, especially in India, which contributes nearly 90% of global production.

Yet this essential crop remains highly vulnerable to Fusarium wilt (FW), a destructive soil-borne disease caused by Fusarium oxysporum f. sp. ciceris. FW routinely causes 10–40% yield losses, and severe outbreaks can wipe out entire fields. The pathogen’s long-term survival in soil, high genetic diversity, and multiple physiological races make chemical control largely ineffective and often overcome resistance in conventionally bred cultivars.

Although genomics and multi-omics studies have highlighted pathways linked to wilt resistance, achieving durable and broad-spectrum immunity requires pinpointing the core molecular regulators that orchestrate defense. One promising route involves activating systemic acquired resistance (SAR), a robust, whole-plant immune response governed by the master regulator non-expressor of pathogenesis-related genes 1 (NPR1).

A recent study published in Plant Cell Reports by a team led by Subhasis Karmakar (ANRF-National Post-Doctoral Fellow; ICAR–Central Rice Research Institute), in collaboration with Sabarinathan Selvaraj (Odisha University of Agriculture and Technology), Subhankar Mondal (Utkal University), and Dipak Gayen (Central University of Rajasthan), has uncovered a powerful new defense strategy for chickpea.

Using multi-omics profiling and CRISPR–Cas9 genome editing, the team demonstrated that heterologous expression of Arabidopsis NPR1 (AtNPR1) significantly enhances Fusarium wilt resistance in transgenic chickpea. They also identified CaDEAD-box20, a previously uncharacterised RNA helicase, as one of the most strongly induced proteins in AtNPR1-expressing plants.

Further protein–protein interaction assays and structural modeling pointed to a potential interaction between AtNPR1 and CaDEAD-box20. Functional studies sealed the discovery: overexpression of CaDEAD-box20 strengthened wilt resistance, while CRISPR–Cas9 knockout plants showed heightened susceptibility. This firmly establishes CaDEAD-box20 as a positive regulator of chickpea immunity.

The author notes,

Our collaborative study reveals AtNPR1-mediated immunity and identifies CaDEAD-box20 as a key wilt-resistance regulator, offering new avenues for durable, broad-spectrum chickpea defense”.

Together, these findings provide the first functional evidence of AtNPR1-mediated defense in chickpea and identify CaDEAD-box20 as a central node in its immune pathway. The study opens up exciting avenues for engineering durable, broad-spectrum resistance against Fusarium wilt, one of the most persistent threats to global chickpea production, and potentially other legumes as well.

Anchored at a state-funded college and supported by partner institutions from western India, RYIM Mumbai brought together colleges and a university with a shared commitment towards building interdisciplinary research programmes. The meeting created a rare opportunity to seed connections, mentorship, and aspiration among early-career researchers and students who most need access to national research networks. RYIM Mumbai contributed to building pathways to interdisciplinary research in two more ways: seeding collaboration across institutional boundaries and equipping early-career researchers with career and funding awareness.

Hosting RYIM Mumbai at Mithibai College demonstrated the value of placing high-quality scientific dialogue directly within teaching-focused institutions. For many participants, particularly postgraduate students and early-career faculty, this was their first opportunity to interact closely with researchers from premier institutions such as TIFR, ACTREC, and those funded by ICMR and ICAR, as well as industry. This reflected a broader reality across many state-funded colleges in India, where strong teaching ecosystems exist alongside limited access to national research networks. The meeting helped them receive mentorship on research funding in India from scientists whose research is supported by multiple central science agencies, thus giving them a sense of how to navigate funding in India.

Interactions with UG and PG students and faculty from Mithibai and other colleges were very fruitful, and the ‘Ask Us Anything’ session was amazing—a cherry on the top”.

- Tejal Gajaria, Navrachana University, Gujarat, an young investigator who participated in RYIM Mumbai.

Panels and workshops focused on collaboration, careers, and leadership complemented and deepened the conversations. Replicating this format could be impactful in bridging the critical gap between research-intensive institutions and colleges that are building research cultures.

The Mumbai meeting aligns strongly with IndiaBioscience’s broader mission to expand the reach of networking platforms such as YIMs and RYIMs, and it provided a way to do so through such engagements with state-funded academic institutions. Crucially, it reinforces a longer-term approach of building sustained engagement through repeated regional meetings and follow-up activities, bringing diverse perspectives on funding, mentorship, and career development into India’s growing scientific network.

“Science beyond borders” - Building collaboration across disciplines and institutions

In line with the central theme, the panel discussion on ‘Collaboration as the catalyst for scientific progress’ highlighted the need to move from isolated research efforts to shared ecosystems accelerated through pooled resources, interdisciplinary thinking, and external networks. Panellists urged young researchers to approach collaboration as a cultural shift, not just a funding requirement. They further highlighted the role of such regional meetings in creating low-barrier entry points to collaborative research projects and leveraging national funding schemes that support high-risk, high-impact, early-stage ideas. This underscored that interdisciplinary research readiness is as much cultural as it is infrastructural.

Mentorship from India’s research ecosystem

Across two days, participants engaged with mentors from premier research institutions, hospitals, funding-linked research centres, and industry incubators. Talks and interactions covered choosing meaningful, locally relevant research questions; translating fundamental research into applied impact; responsible publishing and research visibility; and the growing role of AI, bioinformatics, and data-driven science. These sessions helped demystify research careers and made senior scientists more accessible and relatable, particularly to participants from teaching-focused colleges.

Day 2 concluded with IndiaBioscience’s Crafting Your Career (CYC) workshop, which focused on mapping skills, interests, and values; exploring diverse career pathways in science (academia, industry, entrepreneurship, communication); and building transferable skills such as networking, communication, and professionalism. The workshop used interactive exercises and peer discussions, enabling participants to actively reflect on their career trajectories rather than passively receiving information.

Exposure to mentors across funding agencies also helped participants visualise research careers as navigable, not opaque.

Seeding long-term partnerships and looking ahead

For IndiaBioscience, RYIM Mumbai reaffirmed the importance of meeting communities where they are and being partners in their capacity-building missions by helping them build connections, improve visibility, and sustain engagement with the wider scientific network in India.

Beyond the formal programme, RYIM Mumbai enabled direct institutional conversations with the college leadership on capacity-building workshops for young investigators and postgraduate and UG students.

These conversations indicate that RYIMs can serve as entry points into longer-term institutional engagement rather than standalone events.

As IndiaBioscience looks to extend RYIMs to more cities and institutions, the Mumbai meeting offered important lessons on the value of engaging state-funded colleges, particularly in democratising access to mentorship and networks, fostering collaboration across institutional boundaries, and supporting early-career researchers in settings where such support can be transformative.

Watch the complete event here and here.

Read the RYIM Mumbai 2025 abstract book here.

Bats, the conquerors of the dark, value their caves just like Batman treasures his Gotham city. For some at least, these enclosed dark spaces might seem claustrophobic. But, for 48.5% of 1,400 species of bats, these areas are what they call home. They provide safety, stability, and a suitable environment for hibernation, mating and reproduction. Do these caves serve different purposes in different seasons? Do species differ in how they use such caves for hibernation or reproduction? If they do, then conservation strategies would need to be tailored to meet specific needs of each species while also prioritising caves or habitats that provide maximal conservation output.

A recent study from the National Centre for Biological Sciences (NCBS-TIFR), Bengaluru, published in the Journal of Zoology, sheds light on how bats in the central Himalayas use caves differently depending on seasonal changes. The researchers found that small changes in outside temperatures could alter the temperature within these caves during different seasons, and bats may be able to track such changes in temperatures to optimise energy conservation during hibernation and reproduction.

The research team set foot into 41 limestone caves in Nepal’s Gandaki province in central Himalayas, moving from lower to higher altitudes (400 - 2,700 metres) across seasons (mid-winter, late-winter and early-spring) in search of the dark knights. They visited the caves three times during each phase to increase accuracy. They took care to minimise disturbances- using red torches to avoid startling the bats and reducing noise as much as possible. Bats were not captured for the study, ensuring that they weren’t disturbed during these sensitive periods of hibernation and reproduction. The ecological significance of the caves were also studied using the Bat Cave Vulnerability Index (BCVI). It looks at both the number and types of bats in a cave and the dangers they face and converts it into a score to decide which caves need the most protection.

“Changes in air temperature outside the caves can affect the temperatures inside, especially near the entrance, while deeper areas remain more stable”, says Sanjeev Baniya, the lead author of the study.

What’s interesting is that even though the deeper parts of caves offer a steady climate, bats in the central Himalayas tend to avoid them during winter, by heading towards the lower elevations where they could find food more easily. But when the spring arrives, they come back to these deeper quiet spots to raise their young ones. As a result, the species composition within caves shifts with changes in seasons indicating that bats possibly track insect activity, much like Batman moves from Gotham city to other quieter towns based on the crime rates.

Himalayas warm faster than the global average. This could lead to disrupting the microhabitats within these caves. Bat species in the central Himalayas show very distinct patterns in their cave use on seasonal terms based on factors like cave structure, elevation and temperature. For example, Hipposideros armiger and other bat species chose warmer spots while Rhinolophus luctus chose colder areas within the caves.

Other than the seasonal impact, human activities add to the need for conservation too. For centuries, caves were not just bat shelters but also held religious and cultural significance, as centers for meditation, places of worship, and sanctuaries for monks. They are also noticeable tourist attractions. The artificial lights, noise pollution, presence of visitors, mining activities and construction works can directly or indirectly disrupt their microhabitats, turning these caves less preferable as a roost or home.

Have you ever wondered what would happen if bats disappeared?

Well, let me start by stating this;

Their decline will not just be theirs, it will be ours too.

Bats act as pollinators and seed dispersers, supporting regeneration and replenishment of nature itself. They serve as pest controllers and are involved in nutrient cycling. Any disturbance in their environment would ultimately disrupt our lives too.

“Different bat species show seasonal preferences for specific microclimates. Warmer sites in spring, for example, are chosen to support reproduction. However, even small changes in temperature due to climate change can increase the energetic costs for bats, affecting their ability to save fat or energy during hibernation. If such variations occur in the caves they rely on, they might deplete the stored fat before the reproduction phase thus risking their survival and overall fitness”, says Baniya

Hence, this study calls for targeted conservation strategies based on a seasonal approach. Year round methods are important, but only with consideration towards their seasonal preferences during periods such as hibernation and reproduction. Restricting human activities during such crucial times could help in maintaining life within the caves. Data from BCVI, calls for legal action, patrolling and regulation of tourism to safeguard these underground sites. Long term investigation and protection of these caves are essential, not just for the survival of bats alone, but also for maintaining healthy ecosystem functioning. As cave dwelling invertebrates and vertebrates rely on bat guano, bats, directly, act as keystone species in cave ecosystems.

We’ve known bats through myths and fiction, as symbols of fear and darkness. While in reality, they are small, silent, winged guardians of our ecosystem. Imagine a bat as a solo traveler in search of a place called home. For us, humans, this would mean a new city, a tent under the stars, a cabin or even a room of one’s own. These places act as comfort spaces that help us grow. But the case is sadly different for bats. These bats in the Himalayas, consider their caves as their only comfort zones. Without them, survival is threatened. Hence, protecting their caves isn’t just a responsibility, rather a necessity.

Understanding why cancer therapies work for some patients but fail for others remains one of modern medicine’s greatest puzzles. As the field of oncology turns increasingly towards personalised medicine, uncovering the molecular and immune signatures that shape treatment response has become crucial. In this context, a new study led by Venugopalareddy Mekala offers fresh insights into how changes in epigenetic regulator genes (epiRGs) influence immune behaviour in bladder cancer.

Published recently in Cancer Medicine, the study maps how specific genetic and epigenetic alterations can alter tumour–immune interactions and even predict which patients are more likely to respond to immunotherapy. By integrating multi-omics data and linking it to immune infiltration and clinical outcomes, Mekala and colleagues provide a valuable framework for refining cancer treatment strategies. Their findings not only deepen our understanding of tumour biology but also hold particular relevance for India, where bladder cancer is an emerging health concern and access to precision oncology tools remains limited.

Bladder cancer continues to pose a major clinician challenge worldwide, with patients often responding differently to treatments. Have you ever wondered why some patients respond well while others don’t?

A team led by Venugopalareddy Mekala, an Indian-origin postdoctoral researcher shed new light on this question. Recently, Mekala and his colleagues at Baylor College of Medicine in the United States published research highlighting how genetic alterations in epigenetic regulator genes (epiRGs) can influence tumour behaviour and the body’s immune response. Epigenetic regulation refers to the control of gene activity and protein production without altering the DNA sequence itself, and epiRGs play a central role in managing these modifications.

The study, recently published in Cancer Medicine journal, identified 13 signature scores linked to epiRG aberrations in bladder cancer. These scores are generated by using multiple biological integration of bladder patients. These scores go beyond the usual “is this gene mutated?” approach, they capture the functional impact of these changes on the tumour, offering a more nuanced view of how epigenetic disruptions drive cancer progression.

By analysing data from The Cancer Genome Atlas (TCGA) and other datasets, the researchers found that certain mutations, such as CREBBP, EP300, and CHD7, are associated with increased infiltration of immune cells, including CD8+ and CD4+ T cells, macrophages, and dendritic cells. This increased immune activity was often associated with slower tumour growth and better patient prognosis. In contrast, mutations such as PRDM9 amplification showed lower B-cell infiltration, suggesting possible immune evasion mechanisms by tumours.

The team also explored how these genetic aberrations affect DNA methylation, a key epigenetic mechanism that controls gene expression. Notably, KDM6A mutations were associated with lower global DNA methylation and a unique immune profile, characterised by lower infiltration of most immune cells but slightly higher B-cell presence. Such findings underscore the complex interplay between genetic changes, epigenetic regulation, and immune activity in bladder cancer.

Using these signature scores, the study assessed patients’ responses to PD-L1 immunotherapy, a widely used immune checkpoint inhibitor. The analysis revealed that patients with high scores in specific epiRGs were more likely to benefit from treatment, suggesting that these scores could serve as biomarkers to predict therapeutic response.

Our findings offer a framework for linking genetic and epigenetic alterations to immune behaviour in bladder tumours”, the authors note.

In the Indian context, these results could contribute to the development of more personalised treatment strategies. Bladder cancer is a serious health issue in India with 18,921 new patients diagnosed and 10,231 bladder cancer-related deaths reported yearly, based on GLOBOCAN 2018. The reported incidence rates are 2.4 and 0.7 per 100,000 for males and females, respectively. It is clear that there is a growing burden, with increasing diversity of risk factors (that include tobacco use, contamination of arsenic and nitrate, and carcinogen exposure at work), which reiterates the necessity of personalised treatment approaches in India.

Although genomics-based approaches are still emerging in India, studies like this highlight the potential of integrating genetic profiling with immunotherapy decisions. Challenges remain, including access to high-throughput sequencing technologies and the need for cost-effective implementation in clinical settings. Nevertheless, the study sets a precedent for similar research and collaborations in India, which could help tailor therapies to patient-specific tumour profiles.

This study highlights the importance of combining genomic and epigenetic insights to better understand tumour biology and enhance patient outcomes. The research not only advances our scientific knowledge of bladder cancer but also opens new avenues for precision medicine globally. By mapping how aberrations in epiRG influence both immune infiltration and DNA methylation patterns, Mekala and colleagues have laid a foundation that could guide future research and clinical strategies. With the growing development of AI-driven tools, the author notes that such technologies could, in time, assist in identifying more personalised treatment options for cancer patients in India and beyond.

Modern medicine has fought back with hormone therapies, drugs that block receptors, and cut off cancer’s fuel like signal jammers in a digital war. Yet luminal cancers are resourceful. Some mutate and find alternate pathways; others lie low, waiting for the blockade to weaken. The immune system, normally a vigilant guard, struggles to recognise such familiar-looking foes without risking harm to healthy tissue. Luminal subtypes make up the majority of breast cancer cases worldwide, accounting for more than 50% of cases in India. They may not kill quickly, but their persistence, resistance, and ability to recur make them a formidable challenge- akin to the Hydra’s head that keeps growing back.

At the heart of this resistance lies metabolism, the cancer’s ability to rewire its energy and building blocks. In cancer cells, one of the important survival tricks comes from a specialized type of fat called sphingolipids. At first glance, they look like ordinary building blocks of cell membranes. But in reality, they act like secret couriers, carrying signals that tell cells when to grow, survive, or even resist treatment. When processed into gangliosides (a complex type of glycosphingolipid), they become even more powerful. Gangliosides can tweak how receptors on the cell surface behave, essentially boosting “growth signals” and making cancer cells harder to stop proliferating.

A recent study in PLOS Biology, led by Ujjaini Dasgupta at Ashoka University and Avinash Bajaj at Regional Center for Biotechnology, uncovered a key metabolic and gene regulatory circuit.

A protein called RICTOR, part of the mTORC2 complex (a central growth regulator), normally helps cells survive by activating AKT, a growth-promoting protein. But in luminal cancers, RICTOR goes further: it over activates a transcription factor called ZFX, and through AKT, it changes the cell’s epigenetic settings so that a key enzyme, UDP-glucose ceramide glucosyltransferase or UGCG, is switched on for a longer duration.

UGCG acts like a gateway: it converts simpler lipids (ceramides) into complex ones with a glucose residue (glucosylceramides), which then give rise to gangliosides. Among these, GD3 gangliosides are especially important because they supercharge EGFR, a receptor that drives cancer growth. This creates a vicious cycle; more gangliosides mean stronger signals, which keep the cancer growing and help it resist treatments.

What this study uncovered is not just a hijacked lipid supply line but a carefully wired metabolic and gene regulatory circuit. This circuit connects ganglioside metabolism with cancer progression through the EGFR–mTORC2/RICTOR complex, with multiple nodes: metabolite production, signalling pathways, and transcriptional changes, working together to keep the tumour growing.

One reason chemo-resistance has been so difficult to overcome is our incomplete understanding of how these networks operate and interconnect. Previous studies suggested that shutting down mTORC2 (a central metabolic regulator) or EGFR inhibition could cut off this advantage, but hitting these central hubs (mTORC2 or EGFRs) is like cutting power to an entire city- that may be effective but harmful to healthy systems.

By mapping the circuit, we identified UGCG as a precise choke point. Without it, cancer cells cannot make their protective gangliosides, and the cycle breaks. Recognising these as circuits opens the door to combinatorial strategies, where multiple nodes can be blocked at once, leaving cancer with no escape route”, says Ujjaini.

And here, a fascinating opportunity emerged: a drug called eliglustat, originally developed for Gaucher’s disease (a rare genetic disorder that causes glucosylceramides to build up in organs due to a deficiency in the glucocerebrosidase enzyme), is a known UGCG inhibitor. Though Eliglustat had been tested in breast cancer before, with promising results, more clarity on why it worked would be helpful. This study provided the missing link: eliglustat works because it disarms cancer’s metabolic escape route. In other words, it tricks the trickster by targeting the very mechanism of its proliferation. The implications extend far beyond one drug. “By uncovering how UGCG drives cancer progression, researchers now have a blueprint to design or repurpose other drugs that hit different components of the sphingolipid pathway. Instead of bluntly attacking metabolism, medicine can deliver precision strikes, blocking the cancer’s backup systems without crippling the rest of the body”, says Avinash.

What I enjoyed most about this project was the collaborative spirit of the team, each discussion brought fresh perspectives, and every experiment felt like a shared step forward”, adds Mohammad Nafees Ansari (the first author of this study).

Nafees further adds, “though we had started with a hypothesis to mimic the inhibition of mTORC2 in cancer cells by modulating the sphingolipid candidates, we ended up with an entire metabolic-signaling-gene regulatory circuit with multiple nodes that can be tapped to trick the cancer cells”.

Even more exciting, this approach could be pan-cancer. The sphingolipid–ganglioside axis is a major metabolic regulator across many cancers. Identifying more such circuits will allow researchers to combine strategies, hitting several survival nodes at once. This shift, from treating cancers as isolated problems to mapping their hidden metabolic networks, may be key to overcoming resistance, hopes Ujjaini and Avinash.

The war against cancer is rarely won in a single strike. It is a long campaign of adaptation, counter-adaptation, and persistence. Yet every new insight, like repurposing eliglustat and the discovery of such metabolic networks, reshapes the terrain. Cancer may be the ultimate trickster, but science is learning to play the same game. The rebellion is clever, but it's not invincible.

When I look back at the five days of the Franco-Indian Workshop on Microscopy 2025, held from 6–10 October at Ashoka University, I recall not only the hum of scientific conversations but also the quiet joy of watching months of planning unfold into an event alive with connections and collaborations.

This workshop went far beyond a typical academic gathering. It marked a landmark initiative under the Franco-Indian Campus in the field of Life Sciences for Health, a virtual consortium connecting leading scientists and institutions across India and France. Nearly 20 French researchers from institutions such as Université Côte d'Azur, Sorbonne Université, and École normale supérieure de Lyon, alongside Indian researchers from Indraprastha Institute of Information Technology (IIIT) Delhi, Indian Institute of Technology (IIT) Delhi, Indian Institute of Science (IISc), National Centre for Biological Sciences (NCBS), and the Indian Institutes of Science Education and Research (IISER) Kolkata and Thiruvananthapuram, participated in the workshop. For me, it was also a deeply personal project, one I guided from the first email thread to the final group photograph.

We set out with an ambitious goal: to create a space where biologists from both countries could connect over a unifying theme—microscopy in disease biology. Kasturi Mitra and Sandeep Ameta, organisers from Ashoka University, thoughtfully curated the scientific programme and shaped the structure of the research talks and discussions across the two days of the meeting. I, along with Anupama Ambika Anilkumar from Ashoka Global Research Alliances, coordinated across time zones, institutions, and expectations, aligning every detail - from designing the schedule, curating sessions to managing travel logistics. When the first participants arrived on campus, I realised that every late-night call and checklist had been worth it.

The conference opened on 6 October 2025 with the theme “Disease Biology: Bench to Bed and Back.” Grégor Trumel, Counsellor for Education, Science & Culture and Director, French Institute in India; Tonmoy Kundu, Head of Global Sales, Zeiss Microscopy; Nitin Seth, Director, Indo-French Centre for the Promotion of Advanced Research (CEFIPRA); and Gilles Alcaraz, Director, CNRS India, inaugurated the event and set an inspiring tone. Their remarks reflected a shared optimism about the strengthening Indo-French scientific partnership. Trumel noted,

This workshop stands as a testament to how far a collaboration can go, with India and France advancing science for the greater good.”

K. VijayRaghavan, Science Advisory Chair; Anurag Agrawal, Dean, Trivedi School of Biosciences; and Gautam Menon, Dean of Research, all from Ashoka University, welcomed the delegates. As I listened to them highlight Ashoka’s expanding role as a hub for interdisciplinary research, I felt reaffirmed about the purpose that had guided every planning step of the workshop.

The research talks across the two conference days covered a fascinating range of themes: from cell morphogenesis and cancer biology to neural imaging and artificial intelligence in microscopy. In the keynote lecture, Maithreyi Narasimha, TIFR Mumbai, showed how imaging continues to redefine our understanding of dynamic biological processes and reminded us that seeing truly deepens understanding.

Matteo Rauzi, Université Côte d'Azur, opened the scientific sessions with a striking demonstration of multi-view lightsheet microscopy and laser manipulation to study tissue folding during embryonic development. L.S. Shashidhara, NCBS, offered a translational perspective through molecular and cellular profiling of triple-negative breast cancer in Indian cohorts, showing how imaging aids context-specific disease understanding. Muriel Grammont, ENS Lyon, examined how mechanical and genetic factors drive cell shape changes during epithelial transitions. Pratik Kumar, NCBS, discussed how organic dyes can function as molecular tools beyond imaging, expanding their applications in probing biological systems.

Nicolas Heck, Sorbonne Université, presented 3D confocal imaging and analysis to study connectivity changes in the rodent brain, linking cellular imaging with neuroscience. Tavpritesh Sethi, IIIT Delhi, then highlighted how transformer-based artificial-intelligence architectures, such as Vision Transformers, can transform histopathology by enabling accurate and interpretable analysis of whole-slide images for disease diagnostics.

The second day sustained this momentum with equally engaging sessions. Anup Padmanabhan, Ashoka University, explored the mechanobiology of host–pathogen interactions, while Kasturi Mitra, Ashoka University, revealed how redox-tuned mitochondrial networks prime stemness through quantitative microscopy. Mireille Cormont, Université Côte d'Azur, along with Saravanan Palani and Shovamayee Maharana from IISc, expanded the discussion to cytoskeletal imaging, adipose tissue inflammation, and phase separation biology. Sandeep Ameta, Ashoka University, examined the dynamics within liquid–liquid phase-separated droplets, while Deepak Nair, IISc, and Sylvain Feliciangeli, Université Côte d'Azur, showcased how nanoscale organisation governs ion channel and synaptic function in the brain.

Participants also engaged in parallel breakout sessions exploring microscopy in fundamental and translational biology, high-throughput imaging, and image analysis approaches. Collectively, these sessions showed how microscopy today extends far beyond imaging, it drives discovery, integration, and dialogue across biological scales, from molecules to whole organisms.

The two-day meeting concluded with a visit to the Ashoka–Zeiss Core Imaging Facility, a collaborative platform supporting advanced imaging research, underscoring the shared commitment of France and India to foster excellence in life sciences research. We organised a hands-on microscopy workshop, from 8–10 October 2025, led by Rishi Kant from Zeiss Microscopy for 16 selected participants from Franco-Indian Campus partner institutions, including Université Côte d'Azur, Sorbonne Université, IIT Delhi, IIIT Delhi, Vellore Institute of Technology, and IISER Kolkata. Participants brought their own microscopy samples and trained on advanced imaging systems, exploring high-resolution microscopy techniques.

As one of the organisers, I experienced the other side of the story, the one that rarely appears in conference reports. The weeks leading up to the event overflowed with spreadsheets, video calls, and coordination marathons. I arranged travel for nearly 60 participants, managed logistics for international guests, and refined every detail of the scientific programme. Behind every “successful scientific meeting” stands a web of collaboration, patience, and trust. Our organising team ensured that participants could focus on science while we quietly handled everything else in the background.

The workshop did more than bring together researchers from two nations; it strengthened a network, inspired collaborations, and reinforced the role of microscopy as a bridge between basic and applied science. It reminded me why such platforms matter: they build not only research partnerships but also communities founded on trust, dialogue, and mutual respect.

We owe deep gratitude to our collaborators—CEFIPRA, CNRS India, the French Institute in India, and Zeiss Microscopy—for their unwavering support. Their belief in sustained Indo-French engagement in life sciences made this Franco-Indian Workshop on Microscopy at Ashoka University possible.

This was the very first RYIM in Chhattisgarh, and its timing could not have been better. With ambitious young institutes, an eager student community, and a growing ecosystem for science and technology, Bhilai and Raipur are cities on the rise. The meeting brought this potential into focus, linking regional strengths with national networks and creating space for dialogue across institutions, sectors, and career stages.

Theme and context

The theme emphasising intersectoral convergence in medtech innovation, was both timely and forward-looking. Shubhini Saraf, Director, National Institute of Pharmaceutical Education and Research, Raebareli, set the tone by reminding the audience that the UN’s Sustainable Development Goal of “Good Health and Well-being” is inseparable from broader questions of development. Shubhini advocated for better data systems and robust health frameworks, especially for healthcare and technology to advance together. By centering medtech innovation, the meeting reflected Bhilai and Raipur’s position at the crossroads of industrial strength and scientific growth, and RYIM’s larger mission of encouraging collaborative science in emerging research hubs.

Broader impact for Bhilai and Raipur

The event brought together IIT Bhilai, AIIMS Raipur, NIT Raipur, and several local colleges working side by side to spark conversations that rarely happen in day-to-day institutional silos. From budding science colleges in Bhilai to the IIT, the meeting gave visibility to local talent as young researchers from all these institutions had direct dialogues with senior leaders and peers from other parts of the country. The ‘Clinicians-Meet-Technologists’ sessions brought together physicians, biologists, and entrepreneurs to discuss how ideas can transition from the lab bench to patients and industry floors. Students not only presented their work but were also exposed to new career pathways, mentorship, and practical skills in communication.

Diversity of ideas mirroring diversity of participants: RYIM Bhilai in pictures

Conclusion

Platforms like RYIM will continue to be critical as India’s science landscape becomes more democratised, moving beyond tier 1 institutions into smaller cities to nurture new talent, empower them to connect and collaborate to find better solutions for local problems, and enhance their visibility while doing so.

The RYIM at Bhilai was one such step towards empowering early career researchers at Bhilai and Raipur by exposing them to diverse career pathways in science and strengthening the spirit of collective responsibility for regional advancement in science through excellence. The meeting helped young researchers understand that there are networks that can be built with others across the country to help solve regional problems.